@PRahfeld of @ubcmsl / @AvivoBio presents fascinating data on proof of concept for blood group conversion for human kidneys using ex-vivo machine perfusion at #ATC2023SanDiego
Dreaming of a green 🌍💚 and bright future ? ☘️ 🦠🧫
Listen to a new episode of #Benchtalks featuring #SarahDAdamo and @IrmischSandra and dive into the how, what, why of engineering green life using #synbio.
🎙️Link: https://t.co/jolAnxvfs0
Halle – Vancouver – Leiden. 🛫 #MLU-Alumnus Dr. @prahfeld hat nach seinem Biochemie-Studium an der Uni Halle in Kanada ein Biotech-Unternehmen mitgegründet, das der 37-Jährige heute aus den Niederlanden leitet. https://t.co/5Cg5Llb1Og
@AvivoBio is seeking a Technician, Process Development to support the development of upstream and downstream processes, as well as impurity assay development to support the ongoing development of bacterial-produced enzyme-based product. Link: https://t.co/5leYFSO6yL
ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: https://t.co/1HhlFavdR2 and be sure to play the video on the homepage.
We’re hiring! We are looking for a Project Manager and a Technician to join us on our journey to make blood types obsolete for blood transfusions and organ transplants. Postings listed at the @lifesciences_bc job board https://t.co/uu5wyprgRY
Haiming Luo from @UBC presenting on engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection.
#CGSBanff#glycotime@JayKizLab
Lars Kruse @the_real_larsk @BohlmannLab did present latest results on the production of Montbretin A, a anti-diabetic compound, at the GlycoNet Symposium @glyconet_nce. Great Talk !
#CGSBanff
🅾️A new study shows it's possible to convert #blood type safely in donor organs intended for #transplantation.
Dr. Jayachandran Kizhakkedathu (@JayKizLab) - as well as collaborators @PRahfeld, @withlabb, & many others - are part of this exciting work.
https://t.co/z7HWcxoekP
VACANCY: Fully funded PhD position in my lab. Fascinated by plant specialized metabolism? Come and work with us! #PlantScience#PlantSciJobs@LeidenBiology@UniLeiden
-> study regulation and transport of a novel anti-diabetic plant derived metabolite https://t.co/sKDztGDglI
GlycoNet's Dr. Stephen Withers @UBC is leading Phase 1 trial of a new anti-diabetic compound. By slowing starch breakdown, it could be used to help manage Type 2 #diabetes w/ fewer side effects than other treatments.
Read more: https://t.co/xmqzoaoLIz
#WorldDiabetesDay#Glycomics